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In HSV types 1 and 2, gH forms a noncovalent heterodimer with gL. Previous studies demonstrated that the first 323 amino acids of gH1
and the first 161 amino acids of gL1 are sufficient for gH/gL binding. For gL1, substitution of any of its four cysteine (C) residues (all located
within the gH/gL binding region) destroyed gH binding and function. Although gH1 contains 8 cysteines in its ectodomain, gH 2 contains 7
(C3 of gH1 is replaced by arginine in gH2). We found that mutation of any of the four C-terminal cysteines led to a reduction or loss of gH/gL
function. Mutation of C5 or C6 in gH1 or gH2 rendered the proteins non-functional. However, substitution of C7 and/or C8 in gH1 has a
definite negative impact on cell–cell fusion, although these mutations had less effect on complementation. Remarkably, all four gH1 N-
terminal cysteines could be mutated simultaneously with little effect on fusion or complementation. As gH2 already lacks C3, we constructed a
triple mutant (gH2-C1/2/4) which exhibited a similar phenotype. Since gH1 is known to bind gL2 and vice versa, we wondered whether
binding of gH2 to the heterologous gL1 would enhance the fusion defect seen with the gH2-C2 mutant. The combination of mutant gH2-C2
with wild-type gL1 was nonfunctional in a cell–cell fusion assay. Interestingly, the reciprocal was not true, as gH1-C2 could utilize both gL1
and gL2. These findings suggest that there is a structural difference in the gH2 N-terminus as compared to gH1. We also present genetic
evidence for at least one disulfide bond within gH2, between cysteines 2 and 4.
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Glycoprotein H is absolutely conserved among all
herpesviruses and is essential for virus entry. The functional
form of HSV gH is a non-covalently linked heterodimer
with gL (Hutchinson et al., 1992; Peng et al., 1998; Roop et
al., 1993). This heterodimer is essential for virus–cell and
cell–cell fusion (Spear, 1993). Indeed, four glycoproteins0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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cohen@biochem.dental.upenn.edu (G.H. Cohen).(gB, gD, and gH/gL) as well as a gD receptor are required
for entry of most alphaherpesviruses, including HSV,
pseudorabies virus and bovine herpesvirus type-1 (Spear
et al., 2000). Varicella-zoster virus, which lacks gD, is the
exception (Duus et al., 1995; Maresova et al., 2001).
Although the crystal structure of HSV gD in complex with
one of its receptors (HVEM a.k.a. HveA) has been solved
(Carfi et al., 2001), it offers little insight into how this
complex contributes to the fusion process. The current
hypothesis is that the gD-receptor complex is required to
stabilize the virus–cell interaction and may act as a trigger
for fusion to occur through gB and/or gH/gL. However,
three-dimensional structures of gB and gH/gL have not yet
been solved, nor is it clear how these glycoproteins mediate
fusion.05) 550–562
Fig. 1. Schematic diagram comparing the gH/gL proteins of HSV-1 and
HSV-2. Cysteine residues (bCQ) are numbered from N- to C-terminal
position (1 to 8 for gH, 1 to 4 for gL) at the top, and by amino acid number
at the bottom of each protein representation. Cysteines within the gH
ectodomain are strictly conserved between type-1 and type-2 with the
exception of position 3, which is an arginine (bRQ) in HSV-2. N-linked
glycosylation sites are denoted by lollipop structures. Each molecule also
has a number of potential O-linked glycosylation sites (8 in gH1, 6 in gH2,
9 in gL1, and 10 in gL2) as determined by the NetOGly 3.1 server (http://
www.cbs.dtu.dk/services/NetOGlyc) and referenced in Peng et al., 1998.
For simplicity, these potential O-linked sites have been omitted from our
diagram. The signal sequences (sig, black box) and transmembrane regions
(TMR, gray box) of each protein are also shown.
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(gH-null) if a fusogenic agent (such as polyethylene glycol)
is included in the medium of infected cells (Forrester et al.,
1992), supporting a direct role for gH/gL in virus–cell
fusion. Furthermore, HSV-1 virions inactivated by neutral-
izing anti-gH antibodies or virions lacking gH can still
attach to cells and form a fusion bridge, but are unable to
expand the bridge to allow entry (Fuller and Lee, 1992).
Whereas the N-terminal portion of HSV gH is needed for
interaction with gL (Cairns et al., 2003; Peng et al., 1998;
Westra et al., 1999), the C-terminal portion has been
implicated in fusion. For example, certain mutations in the
transmembrane region (TMR) and cytoplasmic tail affect
fusion (Browne et al., 1996; Harman et al., 2002; Wilson et
al., 1994), as do certain insertions between residues 691 and
the TMR (Galdiero et al., 1997). However, a gDgH chimera
containing this C-terminal gH domain was unable to
substitute for wild-type gH1 in a cell–cell fusion assay
(Cairns et al., 2003). For vesicular stomatitis virus (Jeeten-
dra et al., 2003) and human immunodeficiency virus (Suarez
et al., 2000), the region surrounding the TMR is also
postulated to be critical for fusion. This region may work
cooperatively with a viral fusion domain to bring the viral
and cellular membranes together. However, none of the
herpesvirus glycoproteins involved in fusion contain a
recognizable fusion peptide characteristic of type I or type
II fusion proteins (Jardetzky and Lamb, 2004; Tamm et al.,
2003).
In this study, we used mutagenesis to examine the
importance of the cysteine residues of gH and gL of HSV-1
and HSV-2. Although the gH/gL complexes of these two
serotypes display significant amino acid similarity, they are
antigenically distinct. Polyclonal antibodies (PAbs) to gH1/
gL1 cross-react only weakly or not at all with gH2/gL2
(Peng et al., 1998; Cohen and Eisenberg, unpublished
results). To date, no cross-reactive monoclonal antibodies
(MAbs) have been reported.
Our goal was to obtain information about gH/gL that
would enhance our working structural model (Peng et al.,
1998). We focused on the conserved cysteine residues of
both gL and gH. We determined that all four cysteines of
gL are critical for gH/gL transport and function. Likewise,
the C-terminal cysteines of gH1 (C5 through C8) are
important for gH/gL structure and function. In contrast,
cysteines C1 through C4 of gH1 or gH2 can be mutated
with little or no effect on protein function. This finding is
particularly interesting since two of these cysteines lie
within the predicted gL binding region (Cairns et al.,
2003; Peng et al., 1998; Westra et al., 1999). It was only
when we expressed type-switched heterodimers (gH1/gL2
and gH2/gL1) that we detected significant differences
between some of our N-terminal cysteine mutants and
wild-type gH2. The latter experiments highlighted struc-
tural differences between gH1 and gH2 and also suggested
the presence of a disulfide bond between C2 and C4 of
gH2.Results
The rationale for focusing on cysteine residues of gH and
gL was as follows. First, cysteine is a highly conserved
amino acid which can exist in proteins as a free cysteine or as
part of a disulfide bond. Second, all four cysteines are
conserved between gL1 and gL2, and seven of eight
cysteines are conserved between the ectodomains of gH1
and gH2 (Fig. 1). This conservation is greater than that of
other amino acids of these proteins. Mutant proteins created
here are named according to cysteine number extending from
the N- to C-terminus of each molecule (Fig. 1). Each cysteine
residue was mutated to serine with the exception of gH1
position 3, which was mutated to arginine to mimic that of
gH2 (see Materials and methods). Thus, the context of the
cysteines differ, suggesting that the phenotypes of cysteine
mutants might also differ depending on the serotype. We
will begin by showing the results for the gL1 mutants.
Cysteine substitutions in gL1 ablate gH/gL function
When gH is co-expressed with gL, the gH/gL complex
travels through the Golgi, where both proteins are processed
from immature to mature, glycosylated proteins (Dubin and
Jiang, 1995; Hutchinson et al., 1992; Roop et al., 1993).
When gL is expressed alone, the mature form is transported
from the endoplasmic reticulum to the secretory pathway and
is secreted, leaving little or no mature gL present in cell
extracts (Fig. 2A, lane 1). When co-expressed with gH, the
Fig. 2. gL1 cysteine mutants are nonfunctional. (A) Proteins were separated
by SDS-PAGE and analyzed by Western blotting using the PAb R176. All
gL1 Cys mutants were co-expressed with WT gH1. (B) Quantitative cell–
cell fusion assay. Target CHOK1 cells (expressing the luciferase protein and
the HSV receptor HVEM) were co-cultivated with effector CHO cells
(expressing T7 polymerase, gB1, gD1 and gH1, plus either WT gL1,
mutant gL1, or empty vector DNA) and tested for light production 20 h
later. No difference was seen in fusion between target cells expressing either
nectin-1 (CHO-R3A) or HVEM (CHO-HVEM12), so only CHO-HVEM12
data is presented here. Percent WTwas calculated as follows: (relative light
units (RLU) of test sample / RLU of WT)  100. Each sample was assayed
in at least three separate experiments, and the average value (with standard
deviation represented by error bars) was plotted on the graph.
Fig. 3. Protein profiles of gH and gL present in lysates of transfected 293T
cells expressing C-terminal gH1 cysteine mutants or WT HSV proteins. (A)
Western blot of WT and mutant gH1 co-expressed with WT gL1. The
proteins were separated by SDS-PAGE and analyzed by Western blotting
using the PAb R137. (B) Reactivity of WT and mutant forms of gH1 with
MAb LP11. Lysates of 293T cells transfected with plasmids expressing gL1
and either WT gH1 or a gH1 cysteine mutant were immunoprecipitated
with the anti-gH1-gL1 MAb LP11, separated by SDS-PAGE, and analyzed
by Western blotting. Lysates of cells transfected with gH1 in the absence of
gL1 were used as a negative control. Blots were probed with R137.
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species (Fig. 2A, lane 2). For each of the four single gL1
cysteine mutants, only immature gL was detected when co-
expressed with gH (Fig. 2A, lanes 3–6), indicating that gH/
gL complexes either did not form or were formed but not
transported through the Golgi.
The appearance of the four gL mutants on Western blots
suggested that they would not be functional. To confirm this,
we used a luciferase reporter assay system (Connolly et al.,
2003; Okuma et al., 1999; Pertel et al., 2001) to examine
each gL mutant for its fusogenic properties on HSV receptor-
expressing target cells. None of the four gL mutants were
able to support cell–cell fusion in this assay (Fig. 2B).
It is possible that the single gL cysteine substitutions
prevented disulfide bond formation. By making a double
cysteine substitution of the two binding partners, leaving no
unpaired cysteines to form improper association, proteins
often regain function. This was demonstrated for HSV-1 gD
(Long et al., 1992). We therefore constructed all possible
double cysteine mutants for gL1 (gL1-C1/2, gL1-C1/3, gL1-
C1/4, gL1-C2/3, gL1-C2/4, gL1-C3/4). For all six gL double
mutants, only the immature form of gL was detected uponco-expression with gH, and none were functional in the
fusion assay (data not shown). Since the gL1 double mutants
behaved quite differently than those of gD1, we were unable
to discern any possible disulfide bonding pattern. We
conclude that all of the cysteine residues of gL1 are
important for proper gH/gL maturation, transport and
function.
gH displays a two domain structure: the C-terminal
cysteines 5 through 8
We next tested the effects of cysteine substitutions in gH1.
For ease of presentation, the gH cysteine mutants will be
discussed in two parts: C-terminal mutants (C5–C8) and then
N-terminal mutants (C1–C4). When each C-terminal gH
mutant was co-expressed with gL1, both gH and gL were
readily detected in cell extracts byWestern blot analysis (Fig.
3A). However, extracts of cells transfected with plasmids
expressing gH1-C5 and gH1-C6 exhibited decreased gH
protein expression as compared to WTand no mature gL was
detected, suggesting that these mutant forms did not form a
proper complex with gL. The same effect was seen with C5
and C6 mutants of gH2 (data not shown). In contrast, gH1-
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amount of mature gL was somewhat reduced.
The MAb LP11 reacts only with a functional gH1/gL1
complex (Buckmaster et al., 1984; Hutchinson et al., 1992;
Peng et al., 1998) and is therefore considered the bgold
standardQ for examining proper gH1/gL1 conformation.
Therefore, to examine protein conformation, LP11 was used
to immunoprecipitate each mutant protein complex (Fig.
3B). When co-expressed with gL1, gH1-C7, and gH1-C8
were able to bind LP11 and resembled wild-type gH1 in
reactivity. In contrast, gH1-C5 and gH1-C6 were not
immunoprecipitated either by LP11 (Fig. 3B) or by 53S,
another MAb against a conformation-dependent epitope
(Table 1). Therefore, mutation of either C5 or C6 had a
detrimental effect on the conformation of gH1/gL1 and it is
likely that the proteins containing these substitutions were
misfolded. Since there are no conformational-dependent
MAbs for gH2/gL2, we could not test the gH2 mutants for
proper structure.
Surface expression of the mutant proteins was determined
on CHO-K1 cells (Fig. 4A), the same cell type used in the
quantitative cell–cell fusion assay. Using indirect immuno-
fluorescence, cells transfected with plasmids expressing gL1
and either WT or mutant gH1 were fixed with paraformal-
dehyde and then incubated with a PAb against gH1/gL1. ATable 1
Summary of properties exhibited by HSV-1 gH mutants co-expressed with gL1
gH1 Surface expression gL maturation I
L
WT +++ +++ +
C1 +++ +++ +
C2 +++ +++ +
C3 +++ +++ +
C4 +++ +++ +
C1/2 NDc +++ N
C1/3 ND +++ N
C1/4 ND +++ N
C3/4 ND +++ N
C1/2/3/4 +++ +++ +
C5   
C1/5   
C2/5   
C3/5 +/  
C4/5   
C5/6 +/  
C5/7   
C5/8   
C6   
C1/6   
C6/7   
C6/8   
C7 +++ + +
C8 +++ + +
C1/7 +++ + +
C1/8 +++ + +
C7/8 +++ ++ +
a IP of proteins with the MAb 53S as described in Materials and methods, data
b Results are the average of percent WT activity of at least 3 separate experimen
c ND, not determined.fluorescent-tagged secondary antibody was then used to
detect the presence of gH/gL on the cell surface. Neither
gH1-C5 nor gH1-C6, thought to be misfolded from
immunoprecipitation experiments, were detected on the cell
surface (Fig. 4A). Since they are not present on the cell
surface, gH1-C5 and gH1-C6 could not mediate cell–cell
fusion (Table 1). gH2-C5 and gH2-C6 behaved similarly
(Table 2).
In contrast, gH1-C7 and gH1-C8 were easily detected on
the cell surface by immunofluorescence when co-expressed
with gL (Fig. 4A). We used the cellular enzyme-linked
immunosorbent assay (CELISA) to quantitate surface
protein levels and found that these two proteins were
expressed at levels close to WT gH1/gL1 (Fig. 4B). In the
cell–cell fusion assay, gH1-C7 and gH1-C8 were functional
but the level of fusion was reduced to approximately 25%
WT (Fig. 4C). Interestingly, the amount of cell–cell fusion
seen with gH2-C7 or gH2-C8 was closer to that of WT-gH2
(Fig. 4D). This observation indicates subtle structural
differences in the C-terminal domains of gH1 and gH2.
As a second test of protein function, gH1-C7 and gH1-C8
were tested for their ability to complement the infectivity of a
gH1-null virus. Both mutants complemented at levels 40–
75% that of WT gH1 (Table 1), demonstrating that gH1-C7
and gH1-C8 are functional for both fusion and entry. EveryP Fusionb Complementationb
P11 53Sa
++ +++ 100 100
++ +++ 87 102
++ +++ 127 42
++ +++ 116 70
++ +++ 158 61
D ND 97 44
D ND 106 53
D ND 87 88
D ND 102 123













+ + 24 40
+ + 27 73
+ + 36 77
+ + 44 55
++ ++ 38 93
not shown.
ts.
Fig. 4. (A) Cell surface expression of WT and mutant forms of gH1 by immunofluorescence. CHO-K1 cells were transfected with plasmids for WT and mutant
forms of gH in the absence or presence of gL1. Cells were fixed with 3% paraformaldehyde and then incubated with the PAb R137. The gH1/gL1 complex
(green) was detected using fluorescent-tagged goat-anti-rabbit horseradish peroxidase (GAR-HRP). Cell nuclei were stained with DAPI (blue). (B) Protein
surface expression as detected by CELISA. Transfected CHO-K1 cells were fixed with 3% paraformaldehyde and then incubated with the MAb 37S, which
binds a linear gH1 epitope. gH1 was detected using GAM-HRP. Cells transfected with gH1 in the absence of gL1 were used as a negative control. (C) The
quantitative cell–cell fusion assay was performed as described in Fig. 2B. Target CHO-HVEM12 cells were co-cultivated with effector CHO-K1 cells
(expressing T7 polymerase, gB1, gD1 and gL1, plus either WT gH1, mutant gH1, or empty vector DNA). (D) gH2-C7 and gH2-C8 efficiently fuse cells. The
quantitative fusion assay was performed as described in Fig. 2B. However, due to detrimental effects on signal output when plasmids expressing HSV-2
glycoproteins were used, effector cells were transfected with a combination of plasmids encoding T7 pol, gH2, gL2, gB1, and gD1. The substitution of gB1 and
gD1 for gB2 and gD2 lead to an average 2-log increase in RLUs (data not shown). All gH2 mutants were also tested in a complete type-2 environment (gB2,
gD2, gL2) for the formation of syncytia in B78H1-C10 cells (Cairns et al., 2003). Results from the quantitative luciferase assay always correlated with what
was observed directly on C10 cells (data not shown).
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complementation, and the two assays always mirrored each
other (Table 1). Unfortunately, we do not possess a gH2-null
virus and could not test the gH2 mutants in a complementa-
tion assay. Therefore, we will only present data for cell–cell
fusion as our test of protein function.
As was done with the gL1 mutants, we constructed
double cysteine substitutions of gH1 and asked whether
these manipulations would restore function or enhance
function as compared to single substitution mutants. None
of the double substitutions involving either C5 or C6 were
functional (Table 1). Similar results were obtained for doublemutants of C5 or C6 of gH2 (data not shown). The double
mutant gH1-C7/8 showed only a slight increase in fusion
activity over that of gH1-C7 or gH1-C8 (from 25% to 40%
WT, Table 1). Thus, if there was a disulfide bond between
any of the cysteines in the C-terminal half of gH, we were
unable to confirm its presence using this approach.
The gH N-terminal domain: cysteines 1 through 4
gH1
The N-terminal portion of gH1 is critical for forming the
gL complex and disulfide bonds important for this interaction
Table 2
Summary of properties exhibited by HSV-2 gH mutants co-expressed with
gL1 or gL2
gH2 Surface expressiona gL binding Fusionb
gL1 gL2 gL1 gL2c gL1 gL2
WT +++ +++ +++ +++ 100 100
C1 +++ +++ +++ +++ 172 118
C2  ++ +++ +++ 9 40
C4 +++ +++ +++ +++ 67 78
C1/2  ++ ND ND 6 NDd
C2/4 +++ +++ ND ND 66 NDd
C1/4 ND ND ND ND 48 NDd
C1/2/4 +++ +++ ND ND 86 51
C5 ND ND ND  6 11
C6 ND ND ND  4 7
C7 ND ND ND +++ 79 72
C8 ND ND ND +++ 112 86
a As determined by immunofluorescence, see Materials and methods, data
not shown.
b As determined by luciferase assay; results are the average of percent WT
activity; background for these experiments was 4% WT (gL1) and 9% WT
(gL2).
c As determined by IP with the MAb CHL18, see Materials and methods,
data not shown.
d Fusion activity was near WT-levels, as determined by observation of
syncytia in C10 cells as described in the legend to Fig. 4 (data not shown).
Fig. 5. Protein profiles of gH1 and gL1 present in lysates of transfected
293T cells expressing N-terminal gH1 cysteine mutants or WT HSV
proteins. (A) Western blot of gH1 co-expressed with WT gL1, as described
in Fig. 3A. (B) Reactivity of WT and mutant forms of gH1 with MAb LP11,
as described in Fig. 3B.
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co-expressed with gL1, each of the gH1 N-terminal cysteine
mutants (gH1-C1, gH1-C2, gH1-C3, gH1-C4) formed a
complex with gL1, as judged by the processing of gL1 to the
mature form (Fig. 5A) and by LP11 recognition (Fig. 5B).
Double mutants containing two substitutions between cys-
teines 1 through 4 (gH1-C1/2, gH1-C1/3, gH1-C1/4, gH1-2/
3, gH1-2/4, gH1-C3/4) expressedWTamounts of protein and
cell extracts also contained mature gL (Table 1, data not
shown). Since all mutants looked normal, we wondered if a
quadruple mutant with all four N-terminal cysteines mutated
(gH1-C1/2/3/4) would have similar characteristics. gH1-C1/
2/3/4 had the same properties as WT gH1 both in the level of
expression (Fig. 5A) and recognition by LP11 (Fig. 5B). This
finding was surprising considering that C1 and C2 of gH1 are
located within the predicted gL1 binding region and both
cysteines were proposed to be important for gH1/gL1
structure and function (Peng et al., 1998).
In a test of cell–cell fusion, effector cells expressing any
of the four gH1 N-terminal single or multiple cysteine
mutants were able to fuse target cells at levels equal-to or
greater-than WT gH1 (Fig. 6A). We conclude that for gH1,
C1 through C4 (collectively) are not required for gH to
complex with gL1 or for gH/gL to function in fusion.
gH2
gH2 has a different N-terminal cysteine profile from gH1,
with an arginine at position 3 instead of a cysteine (Fig. 1).
To determine how gH2 N-terminal cysteine mutant proteins
behave, we initially constructed three single-substitution
mutants (gH2-C1, gH2-C2, gH2-C4) and a multiple-sub-
stitution mutant (gH2-C1/2/4). As with gH1, there were nodiscernable differences in the synthesis or processing of the
proteins (data not shown). We then tested each gH2 mutant
in the fusion assay (Fig. 6B). All gH2 N-terminal cysteine
mutants were able to support fusion, although the levels were
consistently reduced from those found for the gH1 mutants.
This observation was most noticeable for gH2-C2, where
fusion reached only 40% WT levels.
This difference, although subtle, prompted us to question
whether there was an underlying structural defect in gH2
caused by the mutation at C2. To test this, we put bpressureQ
on gH’s ability to function in fusion by creating type-
swapped heterodimers. WT gH1 binds gL2 and vice versa,
and both heterotypes support cell–cell fusion (Muggeridge,
2000). Since two of the four N-terminal cysteines lie within
the predicted gL binding region, we reasoned that the gH1/
gL2 and gH2/gL1 heterotypes would also yield information
on gL binding requirements.
gH1-C1, gH1-C2, and gH1-C4 were not significantly
altered in cell–cell fusion when paired with their improper
partner, gL2 (Fig. 7A). Likewise, gH2-C4/gL1 was able to
fuse cells. However, major differences were detected when
the remaining two gH2 mutants were paired with gL1. First,
the heterodimer gH2-C1/gL1 showed an approximately 50%
increase in fusion over WT gH2/gL1. The reason for this is
unknown. Second, gH2-C2/gL1 failed to fuse cells, implying
that there were structural changes in gH2 caused by the C2
Fig. 6. gH N-terminal cysteine mutants fuse cells. (A) gH1 N-terminal
cysteine mutants. Target and effector cells were as described in Fig. 4C. (B)
gH2 N-terminal cysteine mutants. Target and effector cells were as described
in Fig. 4D.
Fig. 7. Cell–cell fusion in the presence of type-switched gH/gL hetero-
dimers. The fusion assay was performed as in Fig. 4C. Effector cells were
transfected with plasmids encoding T7 pol, gB1, gD1, and either gH1 and
gL2 (A) or gH2 and gL1 (B). (C) Fusion using gH2/gL1 is restored to gH2-
C2-substitution mutants only when C4 is also mutated. The fusion assay was
performed as described above, using gH2 mutants containing multiple
cysteine substitutions within the N-terminal region co-expressed with gL1.
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ing homotype partner, gL2. Thus, forming a heterotype with
this mutant resulted in a more significant decrease in
fusogenic ability than see with gH2-C2/gL2 (Fig. 6B),
validating our idea that heterotypes would emphasize subtle
differences in the phenotypes of gH mutants.
Why is gH2-C2/gL1 unable to fuse cells? We hypothe-
sized that mutation of C2 prevented formation of an
important disulfide bond within the N-terminus of gH2.
We constructed double cysteine mutants between gH2 C2
and either C1 or C4. gH2-C1/2/gL1 behaved like gH2-C2/
gL1 and was unable to function in the fusion assay (Fig. 7C).
However, gH2-C2/4/gL1 and gH2-C1/2/4/gL1 were able to
fuse cells (Fig. 7C). Since mutants containing the gH2 C2
substitution were able to fuse cells only when paired with
mutants having a C4 substitution, this suggests that C2–C4
constitutes a disulfide bonded pair.
Further analysis of gH2-C2/gL1
One possible reason for the phenotype of gH2-C2/gL1 is
that gH2-C2 did not form a complex with gL1. To test gL1
binding, extracts from cells transfected with plasmids
expressing the gH2 mutants and gL1 were immunoprecipi-
tated with the anti-gL MAb L4 and then probed via Western
blotting with R176 (Fig. 8A). As expected from the fusion
assay results (Fig. 7B), gH2-C1 was immunoprecipitated byL4. Unexpectedly, gH2-C2 was also immunoprecipitated by
L4, showing that it formed a complex with gL1.
We next considered the possibility that gH2-C2/gL1 was
not expressed on the cell surface, thereby explaining its
inability to mediate cell–cell fusion. To test this possibility,
CHOK1 cells were transfected with gH2 and gL1 plasmids
and tested for surface expression by CELISA. gH2-C2/gL2
was present on the cell surface at levels similar to both WT
gH2/gL2 and gH2-C1/gL2 (Fig. 8B). This correlates with the
ability of gH2-C2/gL2 to function in cell fusion (Fig. 6B). In
contrast, gH2-C2/gL1 was not detected on the cell surface.
Thus, although gH2-C2 was able to form a complex with
gL1, the heterodimer was defective in transport to the cell
surface and explains its inability to function in cell fusion. It
also suggests that gH2-C2 is structurally altered, a phenotype
Fig. 8. gH2-C2 binds gL1 but the complex is not transported to the cell
surface. (A) WT and mutant forms of gH2 were immunoprecipitated from
transfected 293T cell lysates with the agL1 MAb L4, separated by SDS-
PAGE, and analyzed by Western blotting. Blots were probed with the PAb
R176 to detect gH2. (B) Cell surface protein expression as detected by
CELISA. CHO-K1 cells were transfected with plasmids encoding gH2 and
either gL1, gL2, or empty vector. Cells were fixed with 3% paraformalde-
hyde and then incubated with the RAb 176 and GAR-HRP to detect surface-
expressed gH2.
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when partnered with gL2.Discussion
We wanted to improve the current working model for
HSV gH/gL, and chose cysteine residues as our target for
mutagenesis. For gL1, substitution of any of the cysteine
residues disrupted gH/gL maturation and function. This
finding correlates with previous work examining gL1 C-
terminal truncation mutants (Peng et al., 1998), where the
smallest gL mutant still capable of binding the minimal gH
fragment (gH1–323) contained all four gL cysteines. Although
no double-substitution mutants were able to restore function
(data not shown), this does not rule out the possibility that
the four gL cysteines may constitute critical disulfide bonds.
Alternatively, these residues may be required for other
important protein motifs.
Our data support the concept that gH consists of two
separate domains, N- and C-terminal (Anderson et al., 1996;
Cairns et al., 2003; Galdiero et al., 1997). The disulfide bond
we suggest for gH2 (C2–C4) does not cross over this linear
N-/C-terminal barrier, so we cannot predict a physical
interaction between the two halves of the molecule. To date,
the only function associated with the N-terminal domain is
gL binding, which in turn is required for gH/gL maturation,
transport, and incorporation into the virus particle (Hutch-inson et al., 1992; Roop et al., 1993). The C-terminus of the
gH ectodomain is vital in terms of protein structure.
Whereas C7 and C8 are required for efficient cell–cell
fusion in gH1, C5 and C6 are critical to overall protein
structure and function in both gH1 and gH2. Thus, C5 and
C6 are required for proper gH/gL association and transport,
even though they are not within the proposed gL binding
region (Cairns et al., 2003; Galdiero et al., 1997; Peng et al.,
1998; Westra et al., 1999).
The gH C-terminal cysteines (C5 through C8)
In contrast to the N-terminal cysteines, the C-terminal
cysteines are highly conserved across herpesvirus subfami-
lies (Gompels et al., 1988; Klupp and Mettenleiter, 1991;
McGeoch and Davison, 1986; McGeoch et al., 1991).
Cysteines 5 through 8 are present in each of twelve different
herpesviruses we examined from the GenBank sequence
database (National Center for Biotechnology Information,
Bethesda, MD). The regions immediately flanking C5 and
C6 are highly conserved among herpesviruses, so insertions
close to these cysteines may be disrupting a critical structural
motif. In one study (Galdiero et al., 1997), an insertion
between C5 and C6 of HSV-1 gH had a wild-type phenotype,
but insertions immediately flanking C5 and C6 (at residues
552 and 591, respectively) destroyed either total protein
expression or cell surface expression. These flanking
residues are highly conserved across herpesvirus subfami-
lies. These investigators also found that an insertion between
C7 and C8 destroyed cell–cell fusion, but insertions flanking
C7 and C8 had no effect. This finding also correlates with a
conserved region between C7 and C8. Based on both
conservation and the phenotypic groupings of the single
mutants, we can hypothesize the presence of two disulfide
bonds in gH1, C5–C6 and C7–C8. However, double
substitutions of C5/C6 and C7/C8 were unable to improve
or restore function (data not shown). Additional genetic and
biochemical data will have to be accumulated to confirm the
presence of disulfide bonds within the C-terminal region.
The gH N-terminal cysteines (C1 through C4)
From the N-terminal cysteine mutants, we obtained
information about gH structure and the nature of the gH/
gL interaction. From our gH2-C2 data, we predict the
presence of at least one disulfide bond within the gH2 N-
terminus (C2–C4). It is interesting to note that in the
heterotypic environment, gH2-C4 supported fusion while
gH2-C2 did not. If C2–C4 constitutes a disulfide bond, then
a substitution at C4 breaks the same disulfide bond as a
substitution at C2, yet gH2-C4 is able to pair with gL1.
Mutation of C2 would leave C4 as a free cysteine. Most
likely, it is this free cysteine (C4) that renders gH2-C2/gL1
incapable of fusing cells. It is unlikely that mutation of C2 is
at fault, since gH2-C2/4 and gH2-C1/2/4 are able to function
with C2 mutated.
Fig. 9. Working models of HSV gH/gL, adapted from Peng et al. (1998).
Both type-1 (left) and type-2 (right) gH/gL are shown. gL is depicted in
black, the gH N-terminal domain in gray, and the gH C-terminal domain in
black-white stripes. The gH TMR is represented as a white box. The C-
termini of both gL and gH are marked. The gH cysteine positional numbers
are as indicated, with a black bracket depicting the proposed gH2 C2–C4
disulfide bond. A question mark highlights the corresponding region in gH1,
since there is no evidence to date for gH1 N-terminal disulfide bonds.
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the N-terminal region for gH2, it is possible (though
unlikely) that cysteines 1 through 4 of gH1 exist as free
cysteines. We tested up to 40 Ag/mL of purified,
denatured gH1/gL1 with Ellman’s reagent (Ellman,
1959), which reacts with free sulfhydryls to produce a
quantitatable colored product. No signal indicative of free
cysteines was detected (data not shown). Therefore, it is
possible that disulfide bonds also exist among the four
cysteines of the gH1 N-terminal region, yet are not
important to the molecule in the assays tested.
Could the association between gH and gL partially
compensate for disulfide bond formation in the gH N-
terminal domain? It is possible that gH/gL binding
stabilizes the correct folded gH structure that would
otherwise require disulfide bonds for stability. This
hypothesis fits the observation that gH molecules lacking
N-terminal cysteine residues still function at wild-type or
better levels (with the exception of the gH2-C2 mutant).
It also is consistent with the observation that gH2-C2 is
unable to tolerate gL1 as a binding partner; the structural
differences between gL1 and gL2 are such that the C2
mutation (and subsequent lack of a C2–C4 disulfide
bond) makes it impossible to maintain a functional gH2/
gL1 structure.
Structural differences between gH1 and gH2
Is there a structural change in the N-terminal half of gH as
a result of cysteine mutagenesis? For gH1, there were no
structural alterations detected using our assays. Each
cysteine substitution mutant, consisting of both single and
multiple residues, behaved like WT gH1. For gH2, we were
able to detect a change from WT gH2, but only when gH2-
C2 was co-expressed with gL1. If we hypothesize that the
gH2-C2 phenotype is due to a free cysteine at position 4 (as
discussed above), then we can also make the hypothesis that
the region surrounding gH2 C4 is different than that
surrounding gH1 C4. Cysteine 4 is conserved between both
types, yet when unbound, it alters gH2 structure/function but
not gH1. This observation correlates with the fact that all
known gH MAbs to date are type-specific, stressing the
distinctiveness of gH1 and gH2.
We started this project wanting to improve the current
working model for HSV gH/gL (Peng et al., 1998).
Presented in Fig. 9 is our current gH/gL model, for both
type-1 and type-2. In both types, cysteines 5 and 6 are
critical for structure. Also, cysteines 1 through 4 are not
required for gL binding or gH/gL function in a type-
specific (WT) environment. However, we were able to
detect some differences between these proteins. Substitu-
tion of cysteines 7 and 8 affect cell–cell fusion in gH1.
This finding correlates with the work of Galdiero et al.
(1997), as C7 and C8 are in the same region as insertions
that prohibit fusion. On the other hand, C7 and C8
mutations in gH2 had no effect on cell fusion. To date,there have been no published reports on C-terminal
mutations in gH2. So, even with 80% identity and
absolute conservation of cysteine residues within the C-
terminus of gH1 and gH2, some mutants suggest subtle
differences in structure. This is true for the N-terminus as
well. While we predict a C2–C4 disulfide bond in gH2,
we are unable to present evidence for a C2–C4 bond in
gH1 at this time. Our data suggest that the region
surrounding the conserved C4 is different structurally
between gH1 and gH2. Alternate disulfide-bond patterns
and subtle differences in the structure of conserved
herpesvirus glycoproteins have been shown for HSV-2
and human cytomegalovirus gB (Lopper and Compton,
2002; Norais et al., 1996).Materials and methods
Plasmid DNAs
Plasmids pCAGGS/MCS, pT7EMCLuc (encoding the
firefly luciferase gene) and pCAGT7 (encoding T7 polymer-
ase), as well as pPEP98, pPEP99, pPEP100, and pPEP101
(encoding the genes for HSV-1 gB, gD, gH, and gL,
respectively) were gifts of P. G. Spear (Okuma et al., 1999;
Pertel et al., 2001). The genes encoding full-length HSV-2
gB, gD, gH, and gL were each cloned separately into
pCAGGS/MCS. For gB2, plasmid pMM245 (Muggeridge,
2000) was digested with KpnI–BamHI. The resulting small
fragment was ligated into a KpnI–BglII-digested vector
pCAGGS/MCS. For gD2, the US6 gene (encoding gD2) was
PCR amplified from HSV-2 (333) viral DNA from infected
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AGCTGCATTG (HindIII site underlined) and 5V-GGC-
GAATTCCTCCTTCGAGACTCCCTTT (EcoRI site
underlined). This PCR product was digested with HindIII
and EcoRI and ligated into pcDNA3.1 to form pCW357.
Next, the SacI–XhoI fragment from pCW357 was ligated
into vector pCAGGS/MCS to generate plasmid pTC578.
For gL2, we had previously constructed a plasmid
(pWF318) by PCR-amplification from HSV-2 (333) viral
DNA with primers 5V-GCGAAGCTTGCTATGGGGTTCGQ
TCTGTCTGTTTG and 5V-GCCCTCGAGCTAGTTGQ
CGTCGGAGGCGAGTATG. This PCR product was Hin-
dIII–XhoI-digested and ligated into pcDNA3.1 to form
plasmid pWF318. To transfer the gL2 gene into pCAGGS/
MCS for use in the fusion assay, pWF318 was PCR
amplified with primer 5V-GGAGACCCAAGGTACCTA-
GCGTTTAAAC (KpnI site underlined) and a primer
specific to the region 3Vof the pcDNA3.1 multiple cloning
site. The PCR product was then KpnI–XhoI-digested and
ligated into pCAGGS/MCS to generate pTC579. For gH2,
we had previously constructed a plasmid (pCW333) that
encoded a C-terminal truncation of gH2 (residues 1–803).
This plasmid was generated by PCR-amplification of HSV-2
(333) viral DNA with primers 5V-GGCGAATTCCTGG-
CAGCCGGGACGACCATG and 5V-GGGGAATTCTCAGQ
TGGTGGTGGTGGTGGTGGGGGGCGATGGTGGC-
GATGG, EcoRI-digestion, and ligation into pcDNA3.1. To
clone full-length gH2, pCW333 was digested with HindIII–
EcoRI. Next, a portion of the UL22 gene (encoding gH2)
was PCR amplified from HSV-2 (333) viral DNA using
primers 5V-GGCACTCGAGTTTATTCGGGTCTCCA-
CAAAAATGGG (containing an added XhoI site, under-
lined) and 5V-GATCGGATACAAGCTTACGGG (overQ
lapping a native HindIII site). This PCR product was
digested with the indicated restriction enzymes. Lastly,
vector pCAGGS/MCS was digested with EcoRI–XhoI. All
three fragments were gel purified and ligated simultaneously
to create plasmid pTC510, containing full-length gH2. The
gH1 cysteine mutants were created using the QuikChange
site-directed mutagenesis kit (Stratagene Cloning Systems)
as described previously (Connolly et al., 2002). All gH
cysteine residues were changed to serine, with the exception
of the cysteine at gH1 amino acid 404 (C3). Substitution of
C3 to serine exposed a protease cleavage site that prevented
the expression of full-length gH1 (data not shown). There-
fore, C3 was changed to arginine, the residue at the
analogous position in HSV-2 gH (Fig. 1). Primers designed
to mutate individual gH1 cysteine residues were used to
PCR amplify the entire pPEP100 plasmid (encoding full-
length gH1). Plasmids encoding for a single point mutation
were named as follows: gH1-C1 (pTC512), gH1-C2
(pTC513), gH1-C3 (pTC520), gH1-C4 (pTC515), gH1-C5
(pTC516), gH1-C6 (pTC517), gH1-C7 (pTC518) and gH1-
C8 (pTC519). For double and quadruple cysteine mutants,
the above plasmids containing single cysteine substitutions
were re-amplified in the QuikChange procedure using thedesired mutagenic primers. These plasmids, encoding for
multiple cysteine substitutions, were named as follows:
gH1-C1/2 (pTC547), gH1-C1/3 (pTC531), gH1-C1/4
(pTC551), gH1-C2/4 (pTC626), gH1-C3/4 (pTC548),
gH1-C1/2/3/4 (pTC568), gH1-C1/5 (pTC532), gH1-C2/5
(pTC576), gH1-C3/5 (pTC577), gH1-C4/5 (pTC584), gH1-
C5/6 (pTC549), gH1-C5/7 (pTC569), gH1-C5/8 (pTC553),
gH1-C1/6 (pTC533), gH1-C6/7 (pTC570), gH1-C6/8
(pTC567), gH1-C1/7 (pTC607), gH1-C1/8 (pTC608), and
gH1-C7/8 (pTC550). The QuikChange procedure was also
used to mutate individual gL1 cysteine residues (using
plasmid PEP101 as the PCR template) and gH2 cysteine
residues (using plasmid pTC510). Plasmids encoding gL1
cysteine substitutions were named as follows: gL1-C1
(pDL618), gL1-C2 (pDL615), gL1-C3 (pDL616), gL1-C4
(pDL617), gL1-C1/2 (pDL632), gL1-C1/3 (pDL627), gL1-
C1/4 (pDL628), gL1-C2/3 (pDL629), gL1-C2/4 (pDL630),
and gL1-C3/4 (pDL631). Plasmids encoding gH2 cysteine
substitutions were named as follows: gH2-C1 (pTC565),
gH2-C2 (pTC555), gH2-C4 (pTC556), gH2-C5 (pTC557),
gH2-C6 (pTC558), gH2-C7 (pTC559), gH2-C8 (pTC560),
gH2-C1/2 (pDL582), gH2-C1/4 (pDL586), gH2-C2/4
(pDL595), and gH2-C1/2/4 (pDL602). All plasmids were
sequenced to ensure against PCR errors.
Cells
293T cells were grown in Dulbecco modified Eagle
medium (DMEM) containing 10% fetal bovine serum
(FBS). CHO-K1 cells were grown in Ham’s F12 medium
containing 10% FBS. The CHO cell lines CHO-
HVEM12, expressing the HSV receptor HVEM (Terry-
Allison et al., 1998) and CHO-R3A, expressing nectin-1
(Geraghty et al., 1998), were grown in 10% FBS-F12
containing 250 Ag/mL G418. CHO-K1 and CHO-
HVEM12 cells were kindly provided by P. Spear. African
green monkey kidney (Vero) cells (used for the com-
plementation assay) were grown in 5% FBS-DMEM.
Propagation of the gH-null virus SCgH-z on F6 cells
(gifts of A. Minson) was as previously described
(Forrester et al., 1992).
Antibodies
PAbs used in this study were as follows: rabbit (R)
serum R137 was prepared against purified gH1t/gL1
(Peng et al., 1998) and R176 was prepared against gH2t/
gL2. MAbs that recognize linear epitopes and were used
in this study were as follows: L4 (agL1) (Dubin and
Jiang, 1995), and 37S (agH1, gift of M. Zweig)
(Showalter et al., 1981). The MAb CHL18 was obtained
from mouse hybrydomas and recognizes a linear epitope
in gL2 (residues 209–224) (Whitbeck and Shaner,
unpublished data). The MAb LP11, which recognizes a
discontinuous epitope of gH/gL, was a gift of A. Minson
(Buckmaster et al., 1984).
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293T cells were transfected with the desired plasmids
using GenePORTER according to the manufacturer’s proto-
col (Gene Therapy Systems, Inc.). At 48 h post-transfection,
cells were lysed in a buffer consisting of 10 mM Tris pH 8,
150 mMNaCl, 10 mM EDTA, 1% NP-40, 0.5% deoxycholic
acid, and 1 mM phenylmethylsulfonyl fluoride. Typically,
10% of the total cell extract (from a 6-well plate) was
incubated with the appropriate antibody for 18 h at 4 8C.
Proteins were precipitated with protein A agarose beads
(GibcoBRL) for 2 h at 4 8C, separated by electrophoresis on
a 12% SDS-polyacrylamide gel, and detected by Western
blotting with the desired counter-antibody.
Immunofluorescence
CHO-K1 cells were transfected using LipofectAMINE
2000 according to the manufacturer’s protocol (Invitrogen)
with plasmids encoding the HSV glycoproteins gB, gD, gL
and either WT gH or a cysteine mutant. Eighteen hours
post-transfection, cells were seeded onto glass coverslips in
24-well plates at 8  104 cells/well and allowed to
incubate overnight. Next, cells were fixed with 3%
paraformaldehyde for 20 min, quenched with 50 mM
NH4Cl2 for 20 min and then incubated for 30 min with
0.5% bovine serum albumin-phosphate-buffered saline
blocking solution. The following steps were carried out
at room temperature. Cells were incubated with PAbs
R137 or R176 (diluted 1:300 in blocking solution) for 30
min, washed with phosphate buffered saline (PBS), and
then incubated with a fluorescent-tagged secondary anti-
body (1:1000 in blocking solution) for 30 min. Coverslips
were washed three times with PBS, once with distilled
water and mounted to the slides in ProLong Antifade
mounting solution (Molecular Probes). DAPI (4V, 6V-
diamidino-2-phenylindole) was added to the mounting
solution at 1 concentration to stain cell nuclei. Cells
were observed under a Nikon Eclipse E600 microscope at
40 magnification.
CELISA
To detect gH/gL cell surface expression, we used
CELISA (Connolly et al., 2002; Geraghty et al., 2000;
Milne et al., 2001). CHO-K1 cells growing on 6-well plates
were transfected with an appropriate plasmid via the
LipofectAMINE protocol and then re-seeded 24 h later
onto 96-well plates (pretreated with 0.2% gelatin-PBS). At
48 h post transfection, cells were fixed with 3% parafor-
maldehyde for 20 min, quenched with 50 mM NH4Cl for 10
min, and then incubated for 2 h with various concentrations
of agH/gL Ab diluted in 5%FBS-DMEM, all at room
temperature. Secondary antibody GAR-HRP or GAM-HRP
was added and detected with ABTS peroxidase substrate
(Moss, Inc.).Fusion assay
The luciferase reporter gene activation assay (Okuma et
al., 1999; Pertel et al., 2001) was performed in a 96-well
format to quantitate cell–cell fusion as described by
Connolly et al. (2003), with some modifications. Briefly,
CHO-HVEM12 and CHO-R3A cells growing in 6-well
plates and CHO-K1 cells growing in 96-well plates were
transfected using LipofectAMINE 2000. CHO-K1 cells were
transfected with plasmids encoding HSV glycoproteins and
the T7 RNA polymerase (0.04 Ag DNA/well of each in
serum-free OptiMEM) and were designated as effector cells.
CHO-HVEM12 and CHO-R3A cells were transfected with
the plasmid encoding luciferase under control of the T7
promoter (0.4 Ag/well) and were designated as target cells.
Both sets of cells were incubated for 5 h at 37 8C in the
transfection mixture, after which the mixture was removed
and the cells refed with 10% FBS-F12 and allowed to
recover for 1 h. Target cells were then trypsinized and seeded
onto the effector cells in the 96 well plates. At 20 h post co-
cultivation, cells were washed once with PBS and then lysed
in 30 AL of 1 reporter lysis buffer (Luciferase Assay
System, Promega) per well. Cell lysates were incubated at
80 8C for at least 2 h. Finally, 25 AL of lysate from each
sample was mixed with 100 AL of luciferase substrate
(Promega) and immediately assayed for light output by
luminometry.
Complementation assay
The complementation protocol was described in Cairns et
al. (2003). Briefly, Vero cells was transfected using the
GenePORTER protocol overnight and then infected with 106
plaque forming units of SCgH-z. After 2 h, the virus was acid-
inactivated, fresh medium was added and the cells were
incubated overnight. At 24 h post-infection, total virus was
collected by freeze–thawing the cells and collecting the
medium. Virus-containing supernatants were then serially
diluted and titered on F6 cells. Plaques were scored after cells
were fixed using 5% formaldehyde-PBS and stained with
crystal violet.Acknowledgments
Funding for this project was through N.I.H. grant
NS36731 to R. J. E. from the National Institute of
Neurologic Disorders and Stroke and grants AI-18289
and AI-05645 to G. H. C. and R. J. E., respectively,
from the National Institute of Allergy and Infectious
Diseases. T.M.C. was supported by N.I.H. training grant
NS07180.
We are grateful to A. Minson, P. G. Spear and M.
Zweig for providing reagents and M. S. Shaner and M.
Ponce-de-Leon for work done on CHL18. We also thank
our lab colleagues for helpful advice.
T.M. Cairns et al. / Virology 332 (2005) 550–562 561References
Anderson, R.A., Liu, D.X., Gompels, U.A., 1996. Definition of a human
herpesvirus-6 betaherpesvirus-specific domain in glycoprotein gH that
governs interaction with glycoprotein gL: substitution of human
cytomegalovirus glycoproteins permits group-specific complex forma-
tion. Virology 217, 517–526.
Browne, H., Bell, S., Minson, T., Wilson, D.W., 1996. An endoplasmic
reticulum-retained herpes simplex virus glycoprotein H is absent from
secreted virions: evidence for re-envelopment during egress. J. Virol.
70, 4311–4316.
Buckmaster, E.A., Gompels, U., Minson, A., 1984. Characterisation and
physical mapping of an HSV-1 glycoprotein of approximately 115 
10(3) molecular weight. Virology 139, 408–413.
Cairns, T., Milne, R.S.B., Ponce-de-Leon, M., Tobin, D.K., Cohen, G.H.,
Eisenberg, R.J., 2003. Structure–function analysis of herpes simplex
virus (HSV-1) gD and gH/gL: clues from gD/gH chimeras. J. Virol. 77,
6731–6742.
Carfi, A., Willis, S.H., Whitbeck, J.C., Krummenacher, C., Cohen, G.H.,
Eisenberg, R.J., Wiley, D.C., 2001. Herpes simplex virus glycoprotein
D bound to the human receptor HveA. Mol. Cell 8, 169–179.
Connolly, S.A., Landsburg, D.J., Carfi, A., Wiley, D.C., Eisenberg, R.J.,
Cohen, G.H., 2002. Structure-based analysis of the herpes simplex virus
glycoprotein D binding site present on herpesvirus entry mediator
HveA(HVEM). J. Virol. 76, 10894–10904.
Connolly, S.A., Landsburg, D.J., Carfi, A., Wiley, D.C., Cohen, G.H.,
Eisenberg, R.J., 2003. Structure-based mutagenesis of herpes simplex
virus glycoprotein D defines three critical regions at the gD/HveA
interface. J. Virol. 77, 8127–8140.
Dubin, G., Jiang, H., 1995. Expression of herpes simplex virus type 1
glycoprotein L (gL) in transfected mammalian cells: evidence that
gL is not independently anchored to cell membranes. J. Virol. 69,
4564–4568.
Duus, K.M., Hatfield, C., Grose, C., 1995. Cell surface expression and fusion
by the varicella-zoster virus gH:gL glycoprotein complex: analysis by
laser scanning confocal microscopy. Virology 210, 429–440.
Ellman, G.L., 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82,
70–77.
Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N.,
Minson, T., 1992. Construction and properties of a mutant of herpes
simplex virus type 1 with glycoprotein H coding sequences deleted.
J. Virol. 66, 341–348.
Fuller, A.O., Lee, W.C., 1992. Herpes simplex virus type 1 entry through a
cascade of virus–cell interactions requires different roles of gD and gH
in penetration. J. Virol. 66, 5002–5012.
Galdiero, M., Whiteley, A., Bruun, B., Bell, S., Minson, T., Browne, H.,
1997. Site-directed and linker insertion mutagenesis of herpes simplex
virus type 1 glycoprotein H. J. Virol. 71, 2163–2170.
Geraghty, R.J., Krummenacher, C., Cohen, G.H., Eisenberg, R.J., Spear,
P.G., 1998. Entry of alphaherpesviruses mediated by poliovirus
receptor related protein 1 and poliovirus receptor. Science 280,
1618–1620.
Geraghty, R.J., Jogger, C.R., Spear, P.G., 2000. Cellular expression of
alphaherpesvirus gD interferes with entry of homologous and hetero-
logous alphaherpesviruses by blocking access to a shared gD receptor.
Virology 268, 147–158.
Gompels, U.A., Craxton, M.A., Honess, R.W., 1988. Conservation of
glycoprotein H (gH) in herpesviruses: nucleotide sequence of the gH
gene from herpesvirus saimiri. J. Gen. Virol. 69, 2819–2829.
Harman, A., Browne, H., Minson, T., 2002. The transmembrane domain
and cytoplasmic tail of herpes simplex virus type 1 glycoprotein H play
a role in membrane fusion. J. Virol. 76, 10708–10716.
Hutchinson, L., Browne, H., Wargent, V., Davis-Poynter, N., Primorac, S.,
Goldsmith, K., Minson, A.C., Johnson, D.C., 1992. A novel herpes
simplex virus glycoprotein, gL, forms a complex with glycoprotein H
(gH) and affects normal folding and surface expression of gH. J. Virol.
66, 2240–2250.Jardetzky, T.S., Lamb, R.A., 2004. Virology: a class act. Nature 427,
307–308.
Jeetendra, E., Ghosh, K., Odell, D., Li, J., Ghosh, H.P., Whitt, M.A., 2003.
The membrane-proximal region of vesicular stomatitis virus glycopro-
tein G ectodomain is critical for fusion and virus infectivity. J. Virol. 77,
12807–12818.
Klupp, B.G., Mettenleiter, T.C., 1991. Sequence and expression of
the glycoprotein gH gene of pseudorabies virus. Virology 182,
732–741.
Long, D., Wilcox, W.C., Abrams, W.R., Cohen, G.H., Eisenberg, R.J.,
1992. Disulfide bond structure of glycoprotein D of herpes simplex
virus types 1 and 2. J. Virol. 66, 6668–6685.
Lopper, M., Compton, T., 2002. Disulfide bond configuration of human
cytomegalovirus glycoprotein B. J. Virol. 76, 6073–6082.
Maresova, L., Pasieka, T.J., Grose, C., 2001. Varicella-zoster Virus gB and
gE coexpression, but not gB or gE alone, leads to abundant fusion and
syncytium formation equivalent to those from gH and gL coexpression.
J. Virol. 75, 9483–9492.
McGeoch, D.J., Davison, A.J., 1986. DNA sequence of the herpes simplex
virus type 1 gene encoding glycoprotein gH, and identification of
homologues in the genomes of varicella-zoster virus and Epstein–Barr
virus. Nucleic Acids Res. 14, 4281–4292.
McGeoch, D.J., Cunningham, C., McIntyre, G., Dolan, A., 1991.
Comparative sequence analysis of the long repeat regions and adjoining
parts of the long unique regions in the genomes of herpes simplex
viruses types 1 and 2. J. Gen. Virol. 72, 3057–3075.
Milne, R.S.B., Connolly, S.A., Krummenacher, C., Eisenberg, R.J., Cohen,
G.H., 2001. Porcine HveC, a member of the highly conserved HveC/
nectin 1 family, is a functional alphaherpesvirus receptor. Virology 281,
315–328.
Muggeridge, M.I., 2000. Characterization of cell–cell fusion mediated by
herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected
cells. J. Gen. Virol. 81, 2017–2027.
Norais, N., Tang, D., Kaur, S., Chamberlain, S.H., Masiarz, F.R., Burke,
R.L., Marcus, F., 1996. Disulfide bonds of herpes simplex virus type 2
glycoprotein gB. J. Virol. 70, 7379–7387.
Okuma, K., Nakamura, M., Nakano, S., Niho, Y., Matsuura, Y., 1999.
Host range of human T-cell leukemia virus type I analyzed by a
cell fusion-dependent reporter gene activation assay. Virology 254,
235–244.
Peng, T., Ponce de Leon, M., Novotny, M.J., Jiang, H., Lambris, J.D.,
Dubin, G., Spear, P.G., Eisenberg, R.J., Cohen, G.H., 1998. Structural
and antigenic analysis of a truncated form of the herpes simplex virus
glycoprotein gH–gL complex. J. Virol. 72, 6092–6103.
Pertel, P.E., Fridberg, A., Parish, M.L., Spear, P.G., 2001. Cell fusion
induced by herpes simplex virus glycoproteins gB, gD, and gH–gL
requires a gD receptor but not necessarily heparin sulfate. Virology 279,
313–324.
Roop, C., Hutchinson, L., Johnson, D.C., 1993. A mutant herpes simplex
virus type 1 unable to express glycoprotein L cannot enter cells, and its
particles lack glycoprotein H. J. Virol. 67, 2285–2297.
Showalter, S.D., Zweig, M., Hampar, B., 1981. Monoclonal antibodies to
herpes simplex virus type 1 proteins, including the immediate-early
protein ICP 4. Infect. Immun. 34, 684–692.
Spear, P.G., 1993. Entry of alphaherpesviruses into cells. Semin. Virol. 4,
167–180.
Spear, P.G., Eisenberg, R.J., Cohen, G.H., 2000. Three classes of cell
surface receptors for alphaherpesvirus entry. Virology 275, 1–8.
Suarez, T., Gallaher, W.R., Agirre, A., Goni, F.M., Nieva, J.L., 2000.
Membrane interface-interacting sequences within the ectodomain of the
human immunodeficiency virus type 1 envelope glycoprotein: putative
role during viral fusion. J. Virol. 74, 8038–8047.
Tamm, L.K., Crane, J., Kiessling, V., 2003. Membrane fusion: a structural
perspective on the interplay of lipids and proteins. Curr. Opin. Struct.
Biol. 13, 453–466.
Terry-Allison, T., Montgomery, R.I., Whitbeck, J.C., Xu, R., Cohen,
G.H., Eisenberg, R.J., Spear, P.G., 1998. HveA (herpesvirus
T.M. Cairns et al. / Virology 332 (2005) 550–562562entry mediator A), a coreceptor for herpes simplex virus entry,
also participates in virus-induced cell fusion. J. Virol. 72,
5802–5810.
Westra, D.F., Kuiperij, H.B., Welling, G.W., Scheffer, A.J., The, T.H.,
Welling-Wester, S., 1999. Domains of glycoprotein H of herpes simplexvirus type 1 involved in complex formation with glycoprotein L.
Virology 261, 96–105.
Wilson, D.W., Davis-Poynter, N., Minson, A.C., 1994. Mutations in the
cytoplasmic tail of herpes simplex virus glycoprotein H suppress cell
fusion by a syncytial strain. J. Virol. 68, 6985–6993.
